drugset / Trial / NCT01206218
Evaluation of Customized Treatment According to BRCA1 Assessment in Patients With Advanced Gastric Cancer
Phase 2/3
Unknown
96 enrolled
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
RandomizedParallel-groupOpen-labelTreatment
Summary
Evaluation of customized treatment according to BRCA1 assessment in patients with advanced gastric cancer
Timeline
- Start
- 2010-10
- Primary completion
- 2012-10
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Docetaxel | Small molecule | — | — |
| Comparator | Oxaliplatin | Small molecule | — | — |
| Comparator | fluorouracil | Small molecule | — | — |